Roche Holding AG (OTCMKTS:RHHBY) Receives $51.50 Average Price Target from Brokerages

Shares of Roche Holding AG (OTCMKTS:RHHBY) have earned a consensus rating of “Hold” from the eleven brokerages that are currently covering the company, Marketbeat Ratings reports. Six analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $51.50.

A number of brokerages have recently commented on RHHBY. Wolfe Research reissued an “outperform” rating on shares of Roche in a research note on Thursday, February 26th. Argus raised shares of Roche from a “hold” rating to a “buy” rating in a research note on Monday, April 6th. Finally, Morgan Stanley raised shares of Roche from an “underweight” rating to an “equal weight” rating and set a $46.00 target price on the stock in a research note on Friday, April 24th.

Institutional Investors Weigh In On Roche

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Curio Wealth LLC purchased a new stake in Roche during the 3rd quarter worth $25,000. McIlrath & Eck LLC purchased a new stake in Roche during the 1st quarter worth $39,000. Oakworth Capital Inc. increased its stake in Roche by 20.8% during the 4th quarter. Oakworth Capital Inc. now owns 1,658 shares of the company’s stock worth $86,000 after buying an additional 285 shares during the period. Atlas Capital Advisors Inc. purchased a new stake in Roche during the 4th quarter worth $192,000. Finally, Albert D Mason Inc. purchased a new stake in Roche during the 4th quarter worth $207,000.

Roche Trading Up 0.2%

Shares of RHHBY opened at $51.13 on Wednesday. The company’s fifty day moving average is $51.10 and its two-hundred day moving average is $52.49. Roche has a fifty-two week low of $37.51 and a fifty-two week high of $60.85. The company has a current ratio of 1.38, a quick ratio of 1.12 and a debt-to-equity ratio of 0.72.

Roche Company Profile

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.